Branford’s Tangen wins NY contract re superbug
Branford diagnostics company Tangen Biosciences has won a contract from New York state’s health department to develop a point-of-care device to detect Candida auris, a...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Branford diagnostics company Tangen Biosciences has won a contract from New York state’s health department to develop a point-of-care device to detect Candida auris, a...
Connecticut continues to punch above its weight in Bloomberg’s ranking of the most innovative U.S. states, placing fourth for the second year in a row....
Pfizer and their partners at the mRNA specialist BioNTech have published the first glimpse of biomarker data from an early-stage study spotlighting the “robust immunogenicity”...
Bioasis Technologies and Chiesi Global Rare Diseases have entered into a worldwide, exclusive licensing agreement re the Bioasis platform technology, with a focus on four...
Alexion Pharmaceuticals reports that the European Commission has approved ULTOMIRIS® (ravulizumab) — for certain adults and children with atypical hemolytic uremic syndrome (aHUS) … more Separately, Alexion...
BioCT is pleased to welcome Erika Smith to the Board of Directors. Erika is the CEO of ReNetX Bio, a clinical stage, venture funded company in...
The Jackson Laboratory (JAX) reports that the National Cancer Institute has renewed JAX’s prestigious Cancer Center Support Grant for the 34th year. As one of...
Tangen Biosciences has been awarded a contract to develop a point-of-care device for detection of Candida auris, a “superbug” that is resistant to anti-fungal drugs and...
A Yale University spin-off announced $25 million in new funding Wednesday, with plans to design proteins that would defeat “decoy” cells in the body that...
University of Connecticut researcher Dr. George Wu recently published a paper outlining his successful experiment delivering mitochondria to liver cells. This marks the first time researchers...